1996
Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus
Forsyth B, Andiman W, O'Connor T. Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. The Journal Of Pediatrics 1996, 129: 648-655. PMID: 8917228, DOI: 10.1016/s0022-3476(96)70144-0.Peer-Reviewed Original ResearchConceptsClinical staging systemHuman immunodeficiency virusClinical stagingImmunodeficiency virusStaging systemRelative riskPneumocystis carinii pneumoniaDifferent clinical stagesSerious bacterial infectionsTherapeutic decision makingInfant prognosisOpportunistic infectionsPersistent diarrheaCarinii pneumoniaClinical findingsClinical stageMedical recordsClinical trialsOral candidiasisStudy populationEarly deathStage IIIStage IStage IVSurvival curves
1995
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma
Levesque M, Katsaros D, Yu H, Zola P, Sismondi P, Giardina G, Diamandis E. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer 1995, 75: 1327-1338. PMID: 7882283, DOI: 10.1002/1097-0142(19950315)75:6<1327::aid-cncr2820750615>3.0.co;2-p.Peer-Reviewed Original ResearchConceptsEpithelial ovarian carcinomaOvarian carcinomaMutant p53 proteinResidual tumorHistologic gradeOvarian cancerP53 proteinCancer relapseMutant p53 protein overexpressionLonger disease-free survivalKaplan-Meier survival curvesPostsurgical residual tumorDisease-free survivalEarly-stage diseaseSubset of patientsLow histologic gradeMutant p53 protein accumulationAdvanced-stage cancerDifferent clinical stagesP53-negative tumorsP53-positive tumorsP53 protein overexpressionPoor patient outcomesAnti-p53 antibodiesP53 protein accumulation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply